AI in regulatory affairs market to nearly triple by 2030

The Business Research Company says the market for artificial intelligence in regulatory affairs will jump from $1.71 billion in 2025 to $4.78 billion by 2030, as life sciences firms use automation to speed compliance and approvals. North America led the market in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - AI is becoming a core tool for life sciences companies trying to manage more complex regulatory requirements. - The market’s projected jump to $4.78 billion by 2030 signals growing demand for software that can speed approvals, reduce errors and improve compliance. - Faster regulatory workflows can shorten time to market for drugs, biologics and medical devices.

What happened: - The Business Research Company published a 2026 market report on artificial intelligence in regulatory affairs covering market size, trends, forecast and segment analysis. - The market is estimated at $1.71 billion in 2025 and projected to reach $2.11 billion in 2026. - The report forecasts further growth to $4.78 billion by 2030. - North America held the largest market share in 2025. - Asia-Pacific is forecast to be the fastest-growing region in the coming years.

The details: - AI in regulatory affairs uses machine learning, natural language processing and automation to support compliance work in pharmaceuticals, biotechnology and medical devices. - The technology is used to manage large datasets, speed document review and maintain compliance with changing rules. - AI also improves regulatory decision accuracy and streamlines communication with regulators. - The report links recent growth to rising regulatory complexity, larger volumes of documents, faster approval demands, more global clinical trials and broader digitization of regulatory workflows. - The report says future growth will come from regulatory automation, cloud-based compliance platforms, predictive analytics, AI-powered pharmacovigilance and a stronger focus on efficiency. - Key trends include AI-driven regulatory intelligence tools, automated submission management, natural language processing in compliance tasks, cloud-based regulatory solutions and real-time regulatory monitoring. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 report package includes market attractiveness scoring, TAM analysis, company scoring matrices, Excel forecasting dashboards, market hotspots infographics, key technology analysis and updated graphics and tables. - The report offers a free sample here. - The full report is available here.

Between the lines: - The forecast suggests AI is moving from a support tool to a broader operating layer for regulatory teams. - The strongest use cases are in automation-heavy tasks where speed, scale and document handling matter most. - The regional split suggests mature adoption in North America and faster expansion in markets still building digital regulatory infrastructure. - The inclusion of predictive analytics and pharmacovigilance points to AI expanding beyond document processing into higher-value decision support.

What’s next: - The market is expected to keep expanding through 2030 as more compliance workflows shift to AI-enabled systems. - Adoption will likely rise in cloud-based and real-time monitoring tools as regulatory environments become more data-intensive. - Future gains will likely depend on how quickly life sciences companies integrate AI across submission, monitoring and decision-making functions.

The bottom line: - AI in regulatory affairs is turning into a fast-growing software category for life sciences, with demand driven by complexity, compliance pressure and the push for faster approvals.